Biocom California
Oliver Fetzer is a seasoned executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Member of the Board of Directors at Tecan since April 2011 and at Biocom since December 2015, Oliver holds prominent positions within other organizations, including President and CEO of Viridos until August 2024 and previous roles at Arena Pharmaceuticals, Auxilium Pharmaceuticals, and Cerulean Pharma. With a strong background in research and development, Oliver has also led corporate strategies as SVP R&D and Corporate Development at Cubist Pharmaceuticals and as Partner and Managing Director at The Boston Consulting Group. Oliver's academic credentials include an MBA in Strategy and Finance from Carnegie Mellon University, a BS in Biochemistry from the College of Charleston, and a PhD in Pharmaceutical Sciences/Medicinal Chemistry from the Medical University of South Carolina.
This person is not in the org chart
This person is not in any teams
Biocom California
Biocom is a business advocate for life sciences companies in California. It represents more than 750 biotechnology, pharmaceutical, digital health, and medical device or diagnostic companies. The company focuses on accelerating the innovation ecosystem and introducing inventive purchasing programs that advance day-to-day business activities.Biocom provides a public voice to the companies and organizations that support local economies and produce novel solutions to improve the human condition. The company’s membership benefits apply to biotechnology, pharmaceutical, medical device, genomics, and diagnostics companies of all sizes as well as to research universities and institutes, CROs, investors, and service providers.Biocom’s main offices are located in San Diego and Los Angeles, with satellite offices in Washington, D.C. and Tokyo.